FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225816898> ?p ?o ?g. }

• W4225816898 endingPage "1036" @default.
• W4225816898 startingPage "1023" @default.
• W4225816898 abstract "To investigate the effects of pentoxifylline (PTX) in combination with losartan compared to the high dose of losartan alone on serum markers of diabetic nephropathy such as HSP70, copeptin, CRP, and TNFα in patients with type 2 diabetes and nephropathy. A single-center, randomized, double-blind, open-label clinical trial was conducted. Sixty-two patients were eligible and allocated to “PTX + losartan” and “high-dose losartan” arms of the trial using software for random number generation. The first arm received 400 mg PTX two times a day (BD) plus 50 mg losartan daily, while the second arm received 50 mg losartan two times a day (BD) for 12 weeks. Comparison of the biomarkers’ levels before and after treatment was done using paired sample t test variance. ANCOVA was applied to evaluate the comparative efficacy of the two interventions. The effect size was calculated and reported for each biomarker. Urine albumin excretion (UAE), hs-CRP, and HbA1c significantly decreased in both trial arms compared to the baseline measures. Copeptin and TNFα showed significant differences (after vs before) only in the losartan group (p = 0.017 and p = 0.043, respectively). The losartan arm was more successful in reducing TNFα, copeptin, HSP70, systolic blood pressure (SBP), and diastolic blood pressure (DBP) values (p = 0.045, effect size = 7.3%; p = 0.018, effect size 10.1%; p = 0.046, effect size 4.7%, p = 0.001, effect size 23%; p = 0.012, effect size 10.2%, respectively) and the PTX arm was associated with a superior reduction of UAE and hs-CRP levels (p = 0.018, effect size 9.1%; p = 0.028, effect size 9.2%, respectively). Add-on PTX to losartan may have more effective anti-inflammatory and anti-albuminuric roles and therefore may be more applicable in the management of diabetic nephropathy compared with high-dose losartan alone. Trial number IRCT 20121104011356N10." @default.
• W4225816898 created "2022-05-05" @default.
• W4225816898 creator A5022020051 @default.
• W4225816898 creator A5032946573 @default.
• W4225816898 creator A5049233750 @default.
• W4225816898 creator A5050004970 @default.
• W4225816898 creator A5074754761 @default.
• W4225816898 creator A5079470998 @default.
• W4225816898 creator A5086449868 @default.
• W4225816898 creator A5089768281 @default.
• W4225816898 date "2022-04-05" @default.
• W4225816898 modified "2023-10-14" @default.
• W4225816898 title "Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes" @default.
• W4225816898 cites W1446565724 @default.
• W4225816898 cites W1563812129 @default.
• W4225816898 cites W1564756146 @default.
• W4225816898 cites W1865303840 @default.
• W4225816898 cites W1970787934 @default.
• W4225816898 cites W1982341832 @default.
• W4225816898 cites W1984007392 @default.
• W4225816898 cites W1988928503 @default.
• W4225816898 cites W1995988129 @default.
• W4225816898 cites W1996228192 @default.
• W4225816898 cites W1998128768 @default.
• W4225816898 cites W2004177921 @default.
• W4225816898 cites W2012303915 @default.
• W4225816898 cites W2014663082 @default.
• W4225816898 cites W2051296098 @default.
• W4225816898 cites W2055385795 @default.
• W4225816898 cites W2064911760 @default.
• W4225816898 cites W2065447230 @default.
• W4225816898 cites W2068193461 @default.
• W4225816898 cites W2071544636 @default.
• W4225816898 cites W2078711922 @default.
• W4225816898 cites W2083501599 @default.
• W4225816898 cites W2090714091 @default.
• W4225816898 cites W2122389877 @default.
• W4225816898 cites W2128832729 @default.
• W4225816898 cites W2142903252 @default.
• W4225816898 cites W2145943673 @default.
• W4225816898 cites W2153549777 @default.
• W4225816898 cites W2164409045 @default.
• W4225816898 cites W2170688475 @default.
• W4225816898 cites W2180781245 @default.
• W4225816898 cites W2227867460 @default.
• W4225816898 cites W2260779715 @default.
• W4225816898 cites W2288200855 @default.
• W4225816898 cites W2289236631 @default.
• W4225816898 cites W2326273516 @default.
• W4225816898 cites W2400520418 @default.
• W4225816898 cites W2417738757 @default.
• W4225816898 cites W2470332690 @default.
• W4225816898 cites W2480909796 @default.
• W4225816898 cites W2517295947 @default.
• W4225816898 cites W2555391065 @default.
• W4225816898 cites W2571274939 @default.
• W4225816898 cites W2766889331 @default.
• W4225816898 cites W276940052 @default.
• W4225816898 cites W2790376123 @default.
• W4225816898 cites W2791990516 @default.
• W4225816898 cites W2806432643 @default.
• W4225816898 cites W2887738493 @default.
• W4225816898 cites W2890952023 @default.
• W4225816898 cites W2904387867 @default.
• W4225816898 cites W2916807271 @default.
• W4225816898 cites W2954415284 @default.
• W4225816898 cites W2996885533 @default.
• W4225816898 cites W4295989330 @default.
• W4225816898 doi "https://doi.org/10.1007/s13300-022-01250-y" @default.
• W4225816898 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35380410" @default.
• W4225816898 hasPublicationYear "2022" @default.
• W4225816898 type Work @default.
• W4225816898 citedByCount "1" @default.
• W4225816898 countsByYear W42258168982022 @default.
• W4225816898 crossrefType "journal-article" @default.
• W4225816898 hasAuthorship W4225816898A5022020051 @default.
• W4225816898 hasAuthorship W4225816898A5032946573 @default.
• W4225816898 hasAuthorship W4225816898A5049233750 @default.
• W4225816898 hasAuthorship W4225816898A5050004970 @default.
• W4225816898 hasAuthorship W4225816898A5074754761 @default.
• W4225816898 hasAuthorship W4225816898A5079470998 @default.
• W4225816898 hasAuthorship W4225816898A5086449868 @default.
• W4225816898 hasAuthorship W4225816898A5089768281 @default.
• W4225816898 hasBestOaLocation W42258168981 @default.
• W4225816898 hasConcept C126322002 @default.
• W4225816898 hasConcept C126894567 @default.
• W4225816898 hasConcept C134018914 @default.
• W4225816898 hasConcept C2776174234 @default.
• W4225816898 hasConcept C2777180221 @default.
• W4225816898 hasConcept C2779922275 @default.
• W4225816898 hasConcept C2780288358 @default.
• W4225816898 hasConcept C2780404050 @default.
• W4225816898 hasConcept C2781184683 @default.
• W4225816898 hasConcept C2908929049 @default.
• W4225816898 hasConcept C555293320 @default.
• W4225816898 hasConcept C71924100 @default.
• W4225816898 hasConcept C84393581 @default.
• W4225816898 hasConcept C90924648 @default.

• next